Tivic Health® Systems, Inc. (("Tivic Health", NASDAQ:TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today the final results of their pilot research study with The
Critical milestone achieved—the FDA accepted CEL-SCI's selection criteria defining the Multikine target population before surgerySelected patient population had 73% survival with Multikine vs. 45% without Multikine based
Dive into the latest earnings report of ODP Corporation. Despite a sales decline in Q1 FY24, the company saw a significant rise in gross profit. Find out the key factors influencing its financial performance and CEO Gerry Smith's insights on the challenges faced.
PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive
Neurocrine Biosciences, Inc. (NASDAQ:NBIX), today announced the initiation of its Phase 1 first-in-human clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational
This move is viewed as a fresh strategy to safeguard U.S. AI from China, succeeding a series of measures over the past two years aimed at blocking the export of sophisticated AI chips to the Asian country.
Reddit's post-IPO Q1 results reveal losses but highlight a promising trend: its unique appeal across age demographics, positioning it as a platform where users transition into with age, contributing to its soaring stock prices.
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease
Discover insights into LL Flooring Holdings, Inc.'s first-quarter FY24 performance, revealing a 21.7% sales decline to $188.490 million. Despite a 21.5% drop in comparable store sales, the gross margin expanded to 37.8%. However, adjusted EPS fell to $(1.04), missing estimates.